Shots: Boston Scientific signs an agreement with Stark International and SERB SAS to sell its BTG specialty pharma business for $800M in cash. The transaction is expected to close in […]readmore
Tags : Scientific
Shots: Boston acquires Vertiflex, in all-stock transaction. Vertiflex to receive $465M upfront and commercial milestones for 3yrs. with the expected closure of acquisition in Q2’19 The focus of the acquisition […]readmore
Shots: The P-III DELOS study involves assessing of Idebenone (900 mg/day) vs PBO in 64 patients with Duchenne muscular dystrophy (DMD) for 52wks. & P-II DELPHI study with 2-year extension […]readmore